[Developmental dysphasia in children: a comparison of the effectiveness of two modes of peptidergic nootropic therapy].

Nikolay N Zavadenko L A Davydova N Yu Suvorinova

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)

The results of the study confirm the higher effectiveness of two courses of the peptidergic nootropic medication cortexin in the pharmacotherapy of developmental dysphasia in children, aged 3-4 years, conducted over two months, compared with the indication of one treatment course.

Keyphrases

randomized controlled trial
young adults
systematic review
healthcare
emergency department
mesenchymal stem cells
adverse drug
combination therapy
replacement therapy